Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancers|April 14, 2026
Therapy-Induced Senescence Shapes Extracellular Matrix Niches and Fibroblast Function in Head and Neck Squamous Cell CarcinomaJetsy Montero-Vergara, Piotr W Darski, Amy L Harding, et al.
Internal Medicine Journal|February 25, 2020
Factors that predict glycaemic response to sodium-glucose linked transporter (SGLT) inhibitorsAmy L Harding, Naiara Bediaga, Anna Galligan, et al.
Histology and Histopathology|March 14, 2019
Haptoglobin expression in human colorectal cancerÓscar Mariño-Crespo, Elisa Cuevas-Álvarez, Amy L Harding, et al.
EMBO Reports|January 7, 2022
The SUMO protease SENP3 regulates mitochondrial autophagy mediated by Fis1Emily Waters, Kevin A Wilkinson, Amy L Harding, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|December 23, 2018
Characterisation of a functional rat hepatocyte spheroid modelJonathan A Kyffin, Parveen Sharma, Joseph Leedale, et al.
Experimental Dermatology|December 2, 2022
c-Src activation as a potential marker of chemical-induced skin irritation using tissue-engineered skin equivalentsAmy L Harding, Helen E Colley, Inmaculada Barragan Vazquez, et al.
Journal of Materials Chemistry. B|October 17, 2024
Highly porous polycaprolactone microspheres for skeletal repair promote a mature bone cell phenotype <i>in vitro</i>Thomas E Paterson, Robert Owen, Colin Sherborne, et al.
International Journal of Pharmaceutics|October 16, 2024
An advanced in silico model of the oral mucosa reveals the impact of extracellular spaces on chemical permeationSean M Edwards, Amy L Harding, Joseph A Leedale, et al.
JID Innovations : Skin Science From Molecules to Population Health|December 15, 2021
Determination of Chemical Irritation Potential Using a Defined Gene Signature Set on Tissue-Engineered Human Skin EquivalentsAmy L Harding, Craig Murdoch, Simon Danby, et al.
International Journal of Pharmaceutics|March 1, 2026
Translating in vitro buccal permeation to in vivo and whole‑body exposure using in silico cell‑based and physiologically-based pharmacokinetic modellingSean M Edwards, Amy L Harding, Joseph A Leedale, et al.
Pageof 2